SAFC building big pharma relationships to drive growth

By Nick Taylor

- Last updated on GMT

Related tags: Investment, Pharmacology

The impact of the economic downturn is still being felt but SAFC remains "cautiously optimistic" about 2010, believing its close relationships with clients and investment in key emerging markets will generate business.

SAFC president Gilles Cottier spoke with in-PharmaTechnologist at Informex 2010, explaining that the firm uses dedicated high-level salespeople to represent its entire offering to clients, providing a single point of contact that fosters a more strategic interaction.

He went on to say that building this type of trusted relationship is particularly important because of the trend for pharmaceutical and biopharmaceutical firms to enter into wide-ranging strategic partnerships.

Cottier also said that SAFC will continue to invest in emerging international markets to expand its business in 2010, highlighting India, China and Brazil as particularly important growth areas.

Related news

Show more

Related products

show more

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

SQ-USP-Brochure-Thumb-AP-CC

NEW…sugarcane derived USP Squalane from Aprinnova

APRINNOVA – A joint venture of AMYRIS and NIKKOL Group | 26-Feb-2018 | Product Brochure

To date, topical formulation chemists have been restricted to using Squalane derived from the harvesting of shark livers. Neossance Squalane USP, derived...

Related suppliers

Follow us

Products

View more